Minocycline Hydrochloride Dihydrate Aurobindo (Minocycline Hydrochloride)

• Minocycline Hydrochloride is a broad‑spectrum tetracycline antibiotic used to treat bacterial infections affecting the skin, respiratory system, urinary tract and certain intracellular pathogens.
• Acne vulgaris: reduces inflammatory lesions and bacterial colonisation.
• Rickettsial infections: eradicates causative Rickettsia species and limits disease progression.
• Chlamydial infections: eliminates Chlamydia trachomatis and improves clinical symptoms.
• Respiratory tract infections: treats community‑acquired pneumonia and bronchitis caused by susceptible bacteria.
• Urinary tract infections: clears susceptible uropathogens and resolves infection signs.

• Minocycline Hydrochloride penetrates bacterial cells and binds to the 30S ribosomal subunit, blocking the attachment of aminoacyl‑tRNA to the mRNA‑ribosome complex. This inhibition halts protein synthesis, producing a bacteriostatic effect against a wide range of Gram‑positive and Gram‑negative organisms, including atypical intracellular bacteria. Its high lipid solubility facilitates distribution into skin, lung and other tissues, enhancing therapeutic activity.

Minocycline Hydrochloride may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects

• Nausea, vomiting, or abdominal discomfort.
• Photosensitivity: increased sensitivity to sunlight.
• Dizziness or vertigo.
• Skin discoloration: mild hyperpigmentation.

Serious or Rare Side Effects

• Severe hypersensitivity: rash, Stevens‑Johnson syndrome, or anaphylaxis.
• Hepatotoxicity: significant liver injury or elevated enzymes.
• Hematologic abnormalities: aplastic anemia, leukopenia, or thrombocytopenia.
• Intracranial hypertension: headache, visual disturbances, or papilledema.

When prescribing Minocycline Hydrochloride, clinicians should consider several safety precautions to minimise risks.

• Pregnancy: avoid use unless clearly needed, as fetal safety data are limited.
• Breastfeeding: assess risk versus benefit; drug may be excreted in milk.
• Liver disease: monitor hepatic function and adjust therapy if needed.
• Renal impairment: dose adjustment may be required in severe renal dysfunction.
• Drug‑induced photosensitivity: advise patients to limit sun exposure and use protective clothing.
• Store at ambient temperature: keep below 25 °C in the original container, protect from moisture and light.

Minocycline Hydrochloride can interact with other medicines, altering its effectiveness or increasing toxicity.

Major Interactions (Avoid)

• Antacids containing aluminum, calcium, or magnesium: reduce absorption of minocycline.
• Oral iron supplements: chelate the drug and markedly decrease its bioavailability.
• Warfarin: may enhance anticoagulant effect and increase bleeding risk.

Moderate Interactions (Monitor Closely)

• Isotretinoin: combined use may increase risk of intracranial hypertension.
• Cyclosporine: may raise serum concentrations of minocycline.
• Oral contraceptives: may reduce efficacy of the contraceptive, increasing pregnancy risk.